A guide to immunotherapy for COVID-19-Reference-Cited by-同舟云学术

A guide to immunotherapy for COVID-19

Published:2022-01 Issue:1 Volume:28 Page:39-50
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

van de Veerdonk Frank L.^ORCID,Giamarellos-Bourboulis Evangelos^ORCID,Pickkers Peter,Derde Lennie^ORCID,Leavis Helen,van Crevel Reinout,Engel Job J.,Wiersinga W. Joost,Vlaar Alexander P. J.,Shankar-Hari Manu^ORCID,van der Poll Tom^ORCID,Bonten Marc,Angus Derek C.,van der Meer Jos W. M.,Netea Mihai G.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-021-01643-9.pdf

Reference106 articles.

1. Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281–292.e6 (2020).

2. Hoffmann, M. et al. SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280 (2020).

3. Hou, Y. J. et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 182, 429–446.e14 (2020).

4. Jouan, Y., Baranek, T., Si-Tahar, M., Paget, C. & Guillon, A. Lung compartmentalization of inflammatory biomarkers in COVID-19-related ARDS. Crit. Care 25, 120 (2021).

5. Giamarellos-Bourboulis, E. J. et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe 27, 992–1000.e3 (2020).

Cited by 244 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACVPred: Enhanced prediction of anti-coronavirus peptides by transfer learning combined with data augmentation;Future Generation Computer Systems;2024-11

2. Clinical Phenotyping for Prognosis and Immunotherapy Guidance in Bacterial Sepsis and COVID-19;Critical Care Explorations;2024-09

3. Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials;The Lancet Diabetes & Endocrinology;2024-09

4. Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial;Scientific Reports;2024-08-27

5. Computational Design of a Novel Inhibitor Against COVID;Letters in Drug Design & Discovery;2024-08-19